Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Make smart decisions about your research projects.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Targeting inflammation to fight cancer is a new approach with a long history.